IRIS
LOCATI, LAURA DEBORAH
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.412
AS - Asia 1.739
EU - Europa 1.110
SA - Sud America 259
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 74
OC - Oceania 8
Totale 5.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.214
SG - Singapore 519
CN - Cina 426
IT - Italia 362
HK - Hong Kong 271
RU - Federazione Russa 223
VN - Vietnam 196
BR - Brasile 181
FR - Francia 151
DE - Germania 137
BD - Bangladesh 129
CA - Canada 78
GB - Regno Unito 78
IN - India 59
MX - Messico 45
ZA - Sudafrica 34
FI - Finlandia 33
AR - Argentina 27
PL - Polonia 23
TR - Turchia 18
NL - Olanda 17
ES - Italia 16
IQ - Iraq 14
MY - Malesia 14
PR - Porto Rico 13
IE - Irlanda 12
AT - Austria 11
CO - Colombia 11
CR - Costa Rica 11
JP - Giappone 11
CL - Cile 10
EC - Ecuador 10
GT - Guatemala 10
JM - Giamaica 10
PK - Pakistan 10
VE - Venezuela 10
TT - Trinidad e Tobago 9
UZ - Uzbekistan 9
ID - Indonesia 8
IL - Israele 8
SA - Arabia Saudita 8
AU - Australia 6
EG - Egitto 6
LT - Lituania 6
MA - Marocco 6
SC - Seychelles 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
NI - Nicaragua 5
NO - Norvegia 5
PH - Filippine 5
SE - Svezia 5
TN - Tunisia 5
BE - Belgio 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
HN - Honduras 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
PT - Portogallo 4
PY - Paraguay 4
SV - El Salvador 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IR - Iran 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
HR - Croazia 2
KE - Kenya 2
LV - Lettonia 2
QA - Qatar 2
TH - Thailandia 2
UA - Ucraina 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CY - Cipro 1
EE - Estonia 1
FJ - Figi 1
GD - Grenada 1
GP - Guadalupe 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 5.600
Salva come PNG Salva come JPEG
Città #
San Jose 454
Hong Kong 266
Council Bluffs 258
Singapore 238
Dallas 185
Ashburn 163
Beijing 117
Los Angeles 86
Lauterbourg 71
Santa Clara 58
Hanoi 56
Ho Chi Minh City 56
Milan 52
Munich 50
New York 49
Redondo Beach 49
Rome 38
Columbus 37
Moscow 35
Buffalo 31
Mexico City 30
Falkenstein 28
Johannesburg 28
Turku 28
Phoenix 26
Boardman 24
Montreal 22
Orem 22
São Paulo 22
North Bergen 20
Brooklyn 19
Frankfurt am Main 18
Warsaw 18
Shanghai 17
Denver 16
Haiphong 15
Atlanta 14
Chennai 14
London 14
Naples 14
Nuremberg 14
Seattle 13
Changsha 12
Chicago 12
Dublin 11
Guangzhou 11
Kuala Lumpur 11
Pavia 11
Secaucus 11
Charlotte 10
Da Nang 10
Florence 10
Tokyo 10
Turin 10
Yiwu 10
Dhaka 9
Palermo 9
Tashkent 9
Brasília 8
Houston 8
Hyderabad 8
Kingston 8
San José 8
Toronto 8
Düsseldorf 7
Newark 7
Novate Milanese 7
Bari 6
Elk Grove Village 6
Madrid 6
New Delhi 6
Paris 6
Port of Spain 6
San Francisco 6
Amsterdam 5
Ankara 5
Belo Horizonte 5
Boston 5
Bến Tre 5
Calgary 5
Figino 5
Manchester 5
Pittsburgh 5
Poplar 5
Riyadh 5
San Juan 5
Stockholm 5
Suzhou 5
Washington 5
Almaty 4
Amman 4
Baghdad 4
Cleveland 4
Curitiba 4
Desio 4
Guatemala City 4
Guayaquil 4
Helena 4
Helsinki 4
Managua 4
Totale 3.181
Salva come PNG Salva come JPEG
Nome #
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 174
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial 172
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 159
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 121
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 111
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 103
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor–Expressing Salivary Gland Cancer: A Phase II Trial 101
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination 101
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 97
Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study 96
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 95
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 94
Vitamin B12 status in hospitalised cancer patients: Prevalence and clinical implications of depletion and hypervitaminosis 94
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 90
Charged particle radiotherapy for thyroid cancer. A systematic review 85
A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient 84
NR4A3 fusion molecular profile change pathological diagnosis? A case report 82
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 82
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 80
International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34 79
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 79
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 76
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 75
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma 74
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer 74
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 74
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 73
Please mind the gap-about equity and access to care in oncology 73
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 71
Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up 70
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area 65
Major and minor salivary gland tumours 64
Adenoid Cystic carcinoma of minor salivary glands (AdCCmSG): a multidisciplinary update 64
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 63
Current picture of anaplastic thyroid cancer patients' care and meetable needs: A survey of 94 Institutions from the EORTC Endocrine and Head and Neck Cancer Groups 63
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 62
The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients 60
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma 60
Exposure to Occupational Carcinogens and Non-Oncogene Addicted Phenotype in Lung Cancer: Results from a Real-Life Observational Study 59
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 59
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 58
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 57
A novel interface terminology for patient-reported outcomes in home patients monitoring applications 57
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 57
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 56
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe 56
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 56
Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck 56
Salivary gland cancers in elderly patients: challenges and therapeutic strategies 56
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 55
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 55
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study 55
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 55
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 54
How can we address the challenge of distant metastases in HNSCC prognosis? 53
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 53
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer 52
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience 50
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer 50
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy 50
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 50
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells 50
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 49
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 49
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet) 48
Current landscape and support for practical initiation of oncological prehabilitation translatable to thyroid cancer: A position paper 48
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 48
Rare Head and Neck Cancers and Pathological Diagnosis Challenges: A Comprehensive Literature Review 48
An Old but Still Unanswered Question in Recurrent or Metastatic Salivary Duct Carcinoma 46
Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer 46
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 45
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities? 43
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 43
Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer 43
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 43
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice 42
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 41
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma 41
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 41
Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma 41
Current management and future challenges in salivary glands cancer 40
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 39
Assessing Effective Engagement with Digital Behavior Change Intervention: The Case Study of the CAPABLE Project 37
Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma 33
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 31
Malignant salivary gland tumours in families with breast cancer susceptibility 31
Sexual health in women and sexual-gender-minority patients with cancer: A nationwide survey on healthcare professional awareness and attitude on behalf of MITO and AIRO-gynecology group 15
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM) 12
Generative AI and medical oncologists: Be curious, but cautious! 11
Totale 5.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.017
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 1 0 0 0 2
2022/202315 1 0 0 0 1 1 0 0 10 0 2 0
2023/202461 1 6 0 1 1 4 10 3 5 2 11 17
2024/20251.171 9 14 21 18 13 179 104 87 264 46 112 304
2025/20263.282 225 211 222 388 364 132 467 138 293 290 338 214
2026/20271.171 80 232 207 497 155 0 0 0 0 0 0 0
Totale 5.703